These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation]. Grañena A, Gardella S, Marín P, Carreras E, Montserrat E, Rozman C. Sangre (Barc); 1986; 31(3):307-10. PubMed ID: 3092373 [No Abstract] [Full Text] [Related]
3. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Hows JM, Mehta A, Ward L, Woods K, Perez R, Gordon MY, Gordon-Smith EC. Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430 [Abstract] [Full Text] [Related]
4. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060 [Abstract] [Full Text] [Related]
5. Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data). Hows J, Mehta A, Gordon-Smith EC. Cancer Treat Rev; 1983 Sep; 10 Suppl A():53-6. PubMed ID: 6414696 [No Abstract] [Full Text] [Related]
6. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs. Korkmaz A, Oter S, Deveci S, Goksoy C, Bilgic H. J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309 [Abstract] [Full Text] [Related]
8. Incidence of hemorrhagic cystitis after cyclophosphamide therapy with or without mesna: A cohort study and comprehensive literature review. Almalag HM, Alasmari SS, Alrayes MH, Binhameed MA, Alsudairi RA, Alosaimi MM, Alnasser GA, Abuzaid RA, Khalil N, Abouzaid HH, Alarfaj AS. J Oncol Pharm Pract; 2021 Mar; 27(2):340-349. PubMed ID: 32356687 [Abstract] [Full Text] [Related]
9. The management of intractable haematuria. Kouriefs C, Gordon SJ. BJU Int; 2001 Aug; 88(3):301-2. PubMed ID: 11488752 [No Abstract] [Full Text] [Related]
10. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna. Morais MM, Belarmino-Filho JN, Brito GA, Ribeiro RA. Braz J Med Biol Res; 1999 Oct; 32(10):1211-5. PubMed ID: 10510257 [Abstract] [Full Text] [Related]
11. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Haselberger MB, Schwinghammer TL. Ann Pharmacother; 1995 Sep; 29(9):918-21. PubMed ID: 8547741 [Abstract] [Full Text] [Related]
12. Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution study. Saito Y, Kumamoto T, Shiraiwa M, Sonoda T, Arakawa A, Hashimoto H, Tamai I, Ogawa C, Terakado H. Asia Pac J Clin Oncol; 2018 Oct; 14(5):e460-e464. PubMed ID: 29989294 [Abstract] [Full Text] [Related]
13. Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia. Blacklock H, Ball L, Knight C, Schey S, Prentice G. Cancer Treat Rev; 1983 Sep; 10 Suppl A():45-52. PubMed ID: 6414695 [No Abstract] [Full Text] [Related]
14. Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs--a retrospective study. Laberke S, Zenker I, Hirschberger J. Vet Rec; 2014 Mar 08; 174(10):250. PubMed ID: 24463993 [Abstract] [Full Text] [Related]
15. Hemorrhagic cystitis complicating bone marrow transplantation. Letendre L, Hoagland HC, Gertz MA. Mayo Clin Proc; 1992 Feb 08; 67(2):128-30. PubMed ID: 1545575 [Abstract] [Full Text] [Related]
16. The uroprotection of mesna on cyclophosphamide cystitis in rats. Its consequences on behaviour and brain activities. Menétrey D, Bon K, Michiels JF, Lantéri-Minet M. C R Acad Sci III; 1999 Jun 08; 322(6):505-15. PubMed ID: 10457601 [Abstract] [Full Text] [Related]
17. Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation. Link H, Neef V, Niethammer D, Wilms K. Blut; 1981 Nov 08; 43(5):329-30. PubMed ID: 6799018 [No Abstract] [Full Text] [Related]
18. Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis. Matz EL, Hsieh MH. Urology; 2017 Feb 08; 100():16-19. PubMed ID: 27566144 [Abstract] [Full Text] [Related]
19. Comparison of the uroprotective efficacy of mesna and HBO treatments in cyclophosphamide-induced hemorrhagic cystitis. Etlik O, Tomur A, Deveci S, Pişkin I, Pekcan M. J Urol; 1997 Dec 08; 158(6):2296-9. PubMed ID: 9366379 [Abstract] [Full Text] [Related]
20. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, Arthur RR, Jones RJ. J Clin Oncol; 1995 May 08; 13(5):1103-9. PubMed ID: 7738616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]